Pharmacy Retailing is drugs sold in the retail and bought on the internet, not in the hospital.
Scope of the Report:The global average gross margin of pharmacy retailing is in the fluctuation trend, from 12.35% in 2011 to 11.58% in 2015. With the situation of global economy, gross margin will be in decreasing trend in the following five years.
The type of pharmacy retailing includes on-line and off-line. The proportion of off-line in 2015 is about 92.3%, and the proportion of on-line in 2015 is about 7.87%.
North America region is the largest consumption of pharmacy retailing, with a sales revenue market share nearly 44.6% in 2015. Europe is the second largest supplier of pharmacy retailing, enjoying sales revenue market share about 22.6% in 2015.
The global Pharmacy Retailing market is valued at 1386000 million USD in 2018 and is expected to reach 1911000 million USD by the end of 2026, growing at a CAGR of 5.5% between 2020 and 2026.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Pharmacy Retailing.
Europe also play important roles in global market, with market size of xx million USD in 2020 and will be xx million USD in 2026, with a CAGR of xx%.
This report studies the Pharmacy Retailing market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Pharmacy Retailing market by product type and applications/end industries.
Market Segment by Companies, this report covers CVS
Walgreen
Rite Aid
Loblaw
Diplomat
Ahold
AinPharmaciez
Guoda Drugstore
Yixintang
Albertsons
Market Segment by Regions, regional analysis covers North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers On-line
Off-line
Market Segment by Applications, can be divided into OTC
Rx
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
